By patenting their innovations, our clients increase the value of their intellectual property and enhance their ability to compete in the marketplace. We work with individual scientists and engineers, laboratory and research teams, and R&D and product development groups to determine whether, when and where it is in our clients' business and technical interests to seek patent protection. And we don't just file patent applications. Drawing on our experience with patent litigation, corporate financings and technology transactions, we implement IP strategies that conserve resources, add measurable value and give our clients a cost-effective and commercially practical competitive edge.

In 2013 alone, we filed more than 2,000 US and foreign patent applications and obtained more than 800 US and foreign patents for our clients, covering innovations that span the technological spectrum, including aerospace, biochemistry, biotechnology, business methods, chemistry, computer science, fuel cells, genetics, high speed data communication, integrated circuits, materials science, medical devices, nanotechnology, pharmaceuticals, semiconductor devices/processes, and software. We also prepare and prosecute patent applications internationally—under the Patent Cooperative Treaty and in working with a network of seasoned patent lawyers around the world. Our experience extends to appeals, interferences and opposition proceedings within the USPTO, the US Court of Appeals for the Federal Circuit and the European Patent Office. 

Contacts

Sort By
Steinberg, Donald R.

Donald R. Steinberg

Chair, Intellectual Property Department

+1 617 526 6453 (t)

don.steinberg@wilmerhale.com

Love Ph.D., Jane M.

Jane M. Love, Ph.D.

Vice Chair, Intellectual Property Department

+1 212 937 7233 (t)

jane.love@wilmerhale.com

Haag, Joseph F.

Joseph F. Haag

Vice Chair, Intellectual Property Department

+1 650 858 6032 (t)

joseph.haag@wilmerhale.com

Experience

In recent matters, we:

  • Filed and obtained patents covering methods of treatment using NitroMed's commercial drug product, BiDil®—which is targeted to the treatment of heart failure in black patients—and worked with the company on the implementation of strategies for product life cycle management
  • Prosecuted a large and complex family of US and foreign patents for Wyeth and its licensee XCyte, concerning an anti-cancer immunotherapy that is currently in Phase III clinical trials
  • Represented Columbia University in the negotiation of several intellectual property licenses, and in patent prosecution relating to diverse fields such as software applications, integrated circuits, life sciences, chemistry and physical sciences

Publications & News

View

November 4, 2014

U.S. News – Best Lawyers® Release 2015 “Best Law Firms” List, Names WilmerHale International Arbitration “Law Firm of the Year”

The 2015 U.S. News - Best Lawyers® "Best Law Firms" list includes WilmerHale being named a first-tier law firm in 24 national and 62 metro-area rankings. In addition, the firm boasts more than 20 second- and third-tier rankings in several national and metro-area rankings.

October 31, 2014

Stays to Litigation Pending Third-Party IPR and CBM Review

An article by Gregory Lantier and Robert Arcamona published in Intellectual Property Today's October 2014 issue.

October 24, 2014

Patent Law and the Supreme Court: Certiorari Petitions Denied

WilmerHale compiles lists of certiorari petitions that raise patent-law issues. This page contains a consolidated list of all recently denied petitions, organized in reverse chronological order by date of certiorari petition.

October 24, 2014

Patent Law and the Supreme Court: Certiorari Petitions Pending

WilmerHale compiles lists of certiorari petitions that raise patent-law issues. This page contains a consolidated list of all pending petitions, organized in reverse chronological order by date of certiorari petition.

October 24, 2014

Patent Law and the Supreme Court: Certiorari Petitions Granted

WilmerHale compiles lists of certiorari petitions that raise patent-law issues. This page contains a consolidated list of all recently granted petitions, organized in reverse chronological order by date of certiorari petition.

October 13, 2014

WilmerHale Named Best Patent Litigation Firm by The Legal 500 US

WilmerHale has been named the nation's best law firm in the category of IP: Patent Litigation by The Legal 500 United States as part of its inaugural awards program.

August 28, 2014

LMG Life Sciences Honors Firm, Attorneys with Top Rankings for Third Consecutive Year

The 2014 edition of LMG Life Sciences has been released, and it includes the recognition of nine WilmerHale practice areas and 17 attorneys.

August 21, 2014

Choosing Patent Claims to Assert

An article by Evelyn Mak and Dennis Wang published in the August 21, 2014 edition of the Daily Journal.

August 15, 2014

Estoppel as Applied to and From Patent Office Post-Grant Proceedings

An article by Monica Grewal and Richard Crudo published in Bloomberg BNA's Patent, Trademark & Copyright Journal, Vol. 88, No. 1020.

July 17, 2014

WilmerHale and 17 Partners Rank in Managing IP’s 2014-2015 IP Stars Handbook

Managing IP has released its second annual edition of its IP Stars Handbook—a guide that identifies the leading IP firms and lawyers in the United States—prominently ranking WilmerHale and 17 of its partners.

Patent Cert. Petitions

WilmerHale compiles lists of certiorari petitions that raise patent-law issues. This page contains a consolidated list of all recently pending, granted and denied petitions, organized in each listing in reverse chronological order by date of certiorari petition.

Patent Law and the Supreme Court: Certiorari Petitions Pending

Patent Law and the Supreme Court: Certiorari Petitions Granted

Patent Law and the Supreme Court: Certiorari Petitions Denied

For more information on these petitions or other patent appeal matters, contact:

Joseph J. Mueller (+1 617 526 6396, joseph.mueller@wilmerhale.com)
Thomas G. Saunders (+1 202 663 6536, thomas.saunders@wilmerhale.com)
Leslie Pearlson (+1 617 526 6809, leslie.pearlson@wilmerhale.com)